Renal cell carcinoma: Recent developments in diagnostics and therapy;Nierenzellkarzinom: Neue Entwicklungen in Diagnostik und Therapie

Urologe - Ausgabe A

Volumn 49, Issue SUPPL. 1, 2010, Pages 178-184

  Bedke, J ^a   Stenzl, A ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Adjuvant therapy; Diagnostic techniques, surgical; Nephrectomy; Renal cell carcinoma; Targeted therapy

Indexed keywords

CANCER VACCINE;

CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CRYOABLATION; CYTOREDUCTIVE SURGERY; HUMAN; KIDNEY CARCINOMA; LAPAROSCOPY; METASTASIS; NEPHRON SPARING SURGERY; RADIOFREQUENCY ABLATION; REVIEW;

CARCINOMA, RENAL CELL; CHEMOTHERAPY, ADJUVANT; DIAGNOSTIC TECHNIQUES, UROLOGICAL; HUMANS; KIDNEY NEOPLASMS; NEOPLASMS; UROLOGY;

EID: 77958008566     PISSN: 03402592     EISSN: 14330563     Source Type: Journal    
DOI: 10.1007/s00120-010-2378-5     Document Type: Review

References (40)

1. Bedke J, Buse S, Pritsch M et al (2009) Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences. BJU Int 103:1349-1354
2. Bedke J, Pritsch M, Buse S et al (2008) Prognostic stratification of localized renal cell carcinoma by tumor size. J Urol 180:62-67
3. Bedke J, Stenzl A (o J) Immunologic mechanisms in RCC and allogeneic renal transplant rejection. Nat Rev Urol 7:339-347
4. Benway BM, Bhayani SB, Rogers CG et al (2009) Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumors: a multi-institutional analysis of perioperative outcomes. J Urol 182:866-872
5. Benway BM, Bhayani SB, Rogers CG et al (2010) Robot-assisted partial nephrectomy: An International Experience. Eur Urol 57(5):815-820
6. Bird VG, Kanagarajah P, Morillo G et al (2010) Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): The role of 4 phase computerized tomography. World J Urol (in press)
7. Chao DH, Zisman A, Pantuck AJ et al (2002) Changing concepts in the management of renal oncocytoma. Urology 59:635-642
8. Di Lorenzo G, Carteni G, Autorino R et al (2009) Phase II study of sorafenib in patients with sunitinib-refractory metastatic renal cell cancer. J Clin Oncol 27:4469-4474
9. Doehn C, Merseburger AS, Jocham D et al (2007) Is there an indication for neoadjuvant or adjuvant systemic therapy in renal cell cancer?. Urologe A 46:1371-1378
10. Feyerabend S, Gouttefangeas C, Stevanovic S et al (2010) Adjuvant multipeptide vaccination in high-risk renal cell carcinoma. J Clin Oncol 28(Suppl):15051
11. Flanigan RC, Mickisch G, Sylvester R et al (2004) Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol 171:1071-1076
12. Flanigan RC, Salmon SE, Blumenstein BA et al (2001) Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 345:1655-1659
13. Gakis G, Kramer U, Schilling D et al (2010) Small renal oncocytomas: Differentiation with multiphase CT. Eur J Radiol [Epub ahead of print]
14. Gupta K, Miller JD, Li JZ et al (2008) Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev 34:193-205
15. Herrmann E, Bierer S, Wulfing C (2010) Update on systemic therapies of metastatic renal cell carcinoma. World J Urol 28:303-309
16. Jocham D, Richter A, Hoffmann L et al (2004) Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial. Lancet 363:594-599
17. Jung DC, Choi HJ, Kim HY et al (2009) Pulmonary metastasis from renal cell carcinoma: characterization using contrast-enhanced CT attenuation value measurements. J Comput Assist Tomogr 33:54-57
18. Kaouk JH, Goel RK (2009) Single-port laparoscopic and robotic partial nephrectomy. Eur Urol 55:1163-1169
19. Klatte T, Patard JJ, Goel RH et al (2007) Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience. J Urol 178:35-40
20. Kowalczyk KJ, Hooper HB, Linehan WM et al (2009) Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience. J Urol 182:2158-2163
21. Ljungberg B, Cowan N, Hanbury DC et al (2010) Online guidelines on renal cell carcinoma. http://www.uroweb.org/?id=218&gid=4 (assessed June 15th 2010)
22. Ljungberg B, Hanbury DC, Kuczyk MA et al (2007) Renal cell carcinoma guideline. Eur Urol 51:1502-1510
23. May M, Brookman-May S, Hoschke B et al (2010) Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting. Cancer Immunol Immunother 59:687-695
24. May M, Kendel F, Hoschke B et al (2009) Adjuvant autologous tumour cell vaccination in patients with renal cell carcinoma. Overall survival analysis with a follow-up period in excess of more than 10 years. Urologe A 48:1075-1083
25. Merseburger AS, Kuczyk MA (2008) Changing concepts in the surgery of renal cell carcinoma. World J Urol 26:127-133
26. Mickisch GH, Garin A, Van Poppel H et al (2001) Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 358:966-970
27. Motzer RJ, Bacik J, Murphy BA et al (2002) Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol 20:289-296
28. Motzer RJ, Escudier B, Oudard S et al (2010) Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognostic factors. Cancer [Epub ahead of print]
29. Motzer RJ, Escudier B, Oudard S et al (2008) Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet 372:449-456
30. Motzer RJ, Hutson TE, Tomczak P et al (2009) Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol 27:3584-3590
31. Reinhardt C, Zdrojowy R, Szczylik C et al (2010) Results of a randomized phase II study investigating multipeptide vaccination with IMA901 in advanced renal cell carcinoma (RCC). J Clin Oncol 28(Suppl):4529
32. Sablin MP, Negrier S, Ravaud A et al (2009) Sequential sorafenib and sunitinib for renal cell carcinoma. J Urol 182:29-34
33. Sobin LH, Gospodarowicz MK, Wittekind C (2010) TNM classification of malignant tumours. Clin Cancer Res 16(8):2402-2408
34. Sohaib SA, Cook G, Allen SD et al (2009) Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer. Br J Radiol 82:632-639
35. Sternberg CN, Davis ID, Mardiak J et al (2010) Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial. J Clin Oncol 28:1061-1068
36. Stolzenburg JU, Kallidonis P, Hellawell G et al (2009) Technique of laparoscopic-endoscopic single-site surgery radical nephrectomy. Eur Urol 56:644-650
37. Sun M, Lughezzani G, Perrotte P et al (2010) Treatment of metastatic renal cell carcinoma. Nat Rev Urol 7:327-338
38. Szczylik C, Porta C, Bracarda S et al (2008) Sunitinib in patients with or without prior nephrectomy (Nx) in an expanded access trial of metastatic renal cell carcinoma (mRCC). J Clin Oncol 26(Suppl):5124
39. Turna B, Kaouk JH, Frota R et al (2009) Minimally invasive nephron sparing management for renal tumors in solitary kidneys. J Urol 182:2150-2157
40. Wood C, Srivastava P, Bukowski R et al (2008) An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial. Lancet 372:145-154